India's Serum Institute to Make Millions of Potential Coronavirus Vaccine Doses

NEW DELHI — The Serum Institute of India said on Tuesday it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.


Serum, the world’s largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford, which started testing it on humans last week, and is a leader in the global race to develop an antidote to the novel coronavirus.

Some 3.05 million people have been reported to be infected globally and 211,376 have died from COVID-19, the respiratory disease caused by the coronavirus, according to a Reuters tally.

While the Oxford vaccine, called "ChAdOx1 nCoV-19", is yet to be proven to work against COVID-19, Serum decided to start manufacturing it as it had shown success in animal trials and had progressed to tests on humans, Serum Chief Executive Adar Poonawalla said.

Source: https://www.nytimes.com/reuters/2020/04/28/world/europe/28reuters-health-coronavirus-india-vaccine.html

ByReuters

April 28, 2020

10 views0 comments